Vitamin D receptor activation induces peptide YY transcription in pancreatic islets

Endocrinology

Volumn 153, Issue 11, 2012, Pages 5188-5199

  Choi, Mihwa ^a   Ozeki, Jun ^a   Hashizume, Masami ^b   Kato, Shigeaki ^c   Ishihara, Hisamitsu ^a   Makishima, Makoto ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Histo Science Laboratory Co Ltd   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCIUM; LUCIFERASE; MESSENGER RNA; PEPTIDE YY; VITAMIN D RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOCRINE CELL; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE TARGETING; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SINGLE DRUG DOSE;

ANIMALS; CELL LINE; HUMANS; HYDROXYCHOLECALCIFEROLS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE YY; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; RNA, MESSENGER;

EID: 84867809012     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1396     Document Type: Article

References (60)

1. Nagpal S, Na S, Rathnachalam R 2005 Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26:662-687 (Pubitemid 41127276)
2. Makishima M, Yamada S 2005 Targeting the vitamin D receptor: advances in drug discovery. Expert Opin Ther Patents 15:1133-1145
3. Choi M, Makishima M 2009 Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands. Expert Opin Ther Patents 19:593-606
4. Mathieu C, Gysemans C, Giulietti A, Bouillon R 2005 Vitamin D and diabetes. Diabetologia 48:1247-1257 (Pubitemid 41186086)
5. Choi M, Yamada S, Makishima M 2011 Dynamic and ligand-selective interactions of vitamin D receptor with retinoid X receptor and cofactors in living cells. Mol Pharmacol 80:1147-1155
6. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH, Dominguez CE, Jurutka PW 1998 The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13:325-349 (Pubitemid 28146215)
7. Deb DK, Wang Y, Zhang Z, Nie H, Huang X, Yuan Z, Chen Y, Zhao Q, Li YC 2011 Molecular mechanism underlying 1,25-dihydroxyvitamin D regulation of nephrin gene expression. J Biol Chem 286:32011-32017
8. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E 2001 Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxy vitamin D3. Mol Pharmacol 60:1399-1406 (Pubitemid 33144911)
9. 3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 89-90:121-125
10. 28k in human and rat pancreas. Am J Physiol Endocrinol Metab 267:E356-E360
11. Chuang JC, Cha JY, Garmey JC, Mirmira RG, Repa JJ 2008 Research resource: nuclear hormone receptor expression in the endocrine pancreas. Mol Endocrinol 22:2353-2363
12. 3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 120:1490-1497
13. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG 2003 Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 17:509-511
14. Maestro B, Dávila N, Carranza MC, Calle C 2003 Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84:223-230 (Pubitemid 36514839)
15. Lundberg JM, Tatemoto K, Terenius L, Hellström PM, Mutt V, Hökfelt T, Hamberger B 1982 Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 79:4471-4475 (Pubitemid 12052896)
16. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR 1985 Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89:1070-1077 (Pubitemid 16231572)
17. Böttcher G, Alumets J, Håkanson R, Sundler F 1986 Co-existence of glicentin and peptide YY in colorectal L-cells in cat and man. An electron microscopic study. Regul Pept 13:283-291 (Pubitemid 16160256)
18. Greeley Jr GH, Hashimoto T, Izukura M, Gomez G, Jeng J, Hill FL, Lluis F, Thompson JC 1989 A comparison of intraduodenally and intracolonically administered nutrients on the release of peptide-YY in the dog. Endocrinology 125:1761-1765 (Pubitemid 19258607)
19. Böttcher G, Ekman R, Lundqvist G, Ahrén B, Sundler F 1994 Pancreatic peptide YY in alloxan diabetic mice. Pancreas 9:469-474 (Pubitemid 24191714)
20. Upchurch BH, Aponte GW, Leiter AB 1994 Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development 120:245-252 (Pubitemid 24042393)
21. Myrsén-Axcrona U, Ekblad E, Sundler F 1997 Developmental expression of NPY, PYY and PP in the rat pancreas and their coexistence with islet hormones. Regul Pept 68:165-175 (Pubitemid 27132712)
22. Jackerott M, Oster A, Larsson LI 1996 PYY in developing murine islet cells: comparisons to development of islet hormones, NPY, and BrdU incorporation. J Histochem Cytochem 44:809-817 (Pubitemid 26266737)
23. 3-36 physiologically inhibits food intake. Nature 418:650-654
24. Tatemoto K 1982 Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA 79:2514-2518 (Pubitemid 12068399)
25. 3-36-induced feeding reductionin rats. Endocrinology 146:2369-2375
26. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzog H, Le Roux CW, Thomas EL, Bell JD, Withers DJ 2006 Critical role for peptide YY in protein-mediated satiation and bodyweight regulation. Cell Metab 4:223-233 (Pubitemid 44307976)
27. Boey D, Lin S, Enriquez RF, Lee NJ, Slack K, Couzens M, Baldock PA, Herzog H, Sainsbury A 2008 PYY transgenic mice are protected against diet-induced and genetic obesity. Neuropeptides 42:19-30
28. le Roux CW, Batterham RL, Aylwin SJ, Patterson M, Borg CM, Wynne KJ, Kent A, Vincent RP, Gardiner J, Ghatei MA, Bloom SR 2006 Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147:3-8 (Pubitemid 43004254)
29. Boey D, Heilbronn L, Sainsbury A, Laybutt R, Kriketos A, Herzog H, Campbell LV 2006 Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Neuropeptides 40:317-324 (Pubitemid 44634710)
30. Wang G, Leiter AB, Englander EW, Greeley Jr GH 2004 Insulin-like growth factor I increases rat peptide YY promoter activity through Sp1 binding sites. Endocrinology 145:659-666 (Pubitemid 38183808)
31. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, Matsumoto T, Kato S 1997 Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 16:391-396 (Pubitemid 27323308)
32. Ishizawa M, Iwasaki K, Kato S, Makishima M 2009 Hypergravity modulates vitamin D receptor target gene mRNA expression in mice. Am J Physiol Endocrinol Metab 297:E728-E734
33. Ishihara H, Takeda S, Tamura A, Takahashi R, Yamaguchi S, Takei D, Yamada T, Inoue H, Soga H, Katagiri H, Tanizawa Y, Oka Y 2004 Disruption of the WFS1 gene in mice causes progressive β-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet 13:1159-1170 (Pubitemid 38786998)
34. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB 2003 Islet β-cell secretion determines glucagon release from neighbouring α-cells. Nat Cell Biol 5:330-335 (Pubitemid 36432297)
35. Ozeki J, Uno S, Ogura M, Choi M, Maeda T, Sakurai K, Matsuo S, Amano S, Nebert DW, Makishima M 2011 Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice. Toxicology 280:10-17
36. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y, Yamamura K 1990 Establishment of a pancreatic β cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127:126-132 (Pubitemid 20228111)
37. Yamaguchi S, Ishihara H, Yamada T, Tamura A, Usui M, Tominaga R, Munakata Y, Satake C, Katagiri H, Tashiro F, Aburatani H, Tsukiyama-Kohara K, Miyazaki J, Sonenberg N, Oka Y 2008 ATF4-mediated induction of 4E-BP1 contributes to pancreatic β cell survival under endoplasmic reticulum stress. Cell Metab 7:269-276 (Pubitemid 351285529)
38. Krasinski SD, Wheeler MB, Leiter AB 1991 Isolation, characterization, and developmental expression of the rat peptide-YY gene. Mol Endocrinol 5:433-440 (Pubitemid 21923708)
39. Endo-Umeda K, Uno S, Fujimori K, Naito Y, Saito K, Yamagishi K, Jeong Y, Miyachi H, Tokiwa H, Yamada S, Makishima M 2012 Differential expression and function of alternative splicing variants of human liver X receptor α. Mol Pharmacol 81:800-810
40. 3 catabolism in macrophages. Toxicol Sci 109:50-58
41. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA 80:201-204
42. Ishizawa M, Matsunawa M, Adachi R, Uno S, Ikeda K, Masuno H, Shimizu M, Iwasaki K, Yamada S, Makishima M 2008 Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J Lipid Res 49:763-772
43. 3 administration in mice. Drug Metab Dispos 37:2037-2044
44. Nakashima K, Kanda Y, Hirokawa Y, Kawasaki F, Matsuki M, Kaku K 2009 MIN6 is not a pure β cell line but a mixed cell line with other pancreatic endocrine hormones. Endocr J 56:45-53
45. Powers AC, Efrat S, Mojsov S, Spector D, Habener JF, Hanahan D 1990 Proglucagon processing similar to normal islets in pancreatic α-like cell line derived from transgenic mouse tumor. Diabetes 39:406-414 (Pubitemid 20111420)
46. Liu CD, Hines OJ, Whang EE, Laird EC, Skotzko MJ, Zinner MJ, Ashley SW, McFadden DW 1995 Pancreatic peptide YY mRNA levels increase during adaptation after small intestinal resection. J Surg Res 58:6-11
47. le Roux CW, Aylwin SJ, Batterham RL, Borg CM, Coyle F, Prasad V, Shurey S, Ghatei MA, Patel AG, Bloom SR 2006 Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243:108-114 (Pubitemid 43054062)
48. Compher CW, Badellino KO, Boullata JI 2008 Vitamin D and the bariatric surgical patient: a review. Obes Surg 18:220-224
49. Pournaras DJ, Glicksman C, Vincent RP, Kuganolipava S, Alaghband-Zadeh J, Mahon D, Bekker JH, Ghatei MA, Bloom SR, Walters JR, Welbourn R, le Roux CW 2012 The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 153:3613-3619
50. Oliver-Krasinski JM, Stoffers DA 2008 On the origin of the β cell. Genes Dev 22:1998-2021
51. Bikle DD, Teichert A, Arnold LA, Uchida Y, Elias PM, Oda Y 2010 Differential regulation of epidermal function by VDR coactivators. J Steroid Biochem Mol Biol 121:308-313
52. Chuma M, Endo-Umeda K, Shimba S, Yamada S, Makishima M 2012 Hairless modulates ligand-dependent activation of the vitamin D receptor-retinoid X receptor heterodimer. Biol Pharm Bull 35:582-587
53. Gardiner JV, Jayasena CN, Bloom SR 2008 Gut hormones: a weight off your mind. J Neuroendocrinol 20:834-841 (Pubitemid 351858737)
54. Cox HM 2008 Endogenous PYY and NPY mediate tonic Y1- and Y2-mediated absorption in human and mouse colon. Nutrition 24:900-906
55. Cox HM, Tough IR, Woolston AM, Zhang L, Nguyen AD, Sainsbury A, Herzog H 2010 Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab 11:532-542
56. Sam AH, Gunner DJ, King A, Persaud SJ, Brooks L, Hostomska K, Ford HE, Liu B, Ghatei MA, Bloom SR, Bewick GA 2012 Selective ablation of peptide YY cells in adult mice reveals their role in β cell survival. Gastroenterology 143:459-468
57. Grandt D, Siewert J, Sieburg B, al Tai O, Schimiczek M, Goebell H, Layer P, Eysselein VE, Reeve Jr JR, Müller MK 1995 Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors. Pancreas 10:180-186
58. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC 2006 Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98:451-459
59. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, Qi D, Patel AV, Helzlsouer KJ, Weinstein SJ, McCullough ML, Purdue MP, Shu XO, Snyder K, Virtamo J, Wilkins LR, Yu K, Zeleniuch-Jacquotte A, Zheng W, Albanes D, Cai Q, Harvey C, Hayes R, Clipp S, Horst RL, Irish L, Koenig K, Le Marchand L, Kolonel LN 2010 Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172:81-93
60. 3 analogue decreases cell number. Pancreatology 3:41-46